For decades, vulvodynia was considered a mystery condition with few answers and limited treatment options. That's no longer the case.
In this episode, Dr. Andrew Goldstein - Clinical Professor at George Washington University and one of the world's leading experts on vulvar and pelvic pain - explains how 25 years of dedicated research has transformed our understanding of vulvodynia from a "black box" into a condition with identifiable causes and effective treatments.
In this episode, you'll learn:
- Why vulvodynia wasn't part of standard medical training (and what's changing)
- The real causes behind vulvar pain - from mast cell inflammation to hormonal triggers
- How birth control pills can cause vulvodynia in some women (and the genetic reasons why)
- Why the majority of pelvic pain patients have been gaslit - and the JAMA study that proves it
- The truth about vestibulectomy surgery: who needs it (only 7% of patients) and the 97% success rate
- Exciting new treatments on the horizon, including ketotifen for mast cell stabilization
Dr. Goldstein, past president of the International Society for the Study of Women's Sexual Health, has published over 170 peer-reviewed articles and co-authored 8 books on female sexual pain. He shares the revolutionary research from the 2023 Vulvodynia Therapeutics Summit and explains why vulvodynia is no longer a mystery condition - it's a solvable problem with tailored treatments.
Whether you're living with vulvodynia, vestibulodynia, vaginismus, or other forms of pelvic pain, this episode offers validation, answers, and hope for your healing journey.
🎧 Topics covered: vulvodynia causes, hormonally mediated vulvodynia, provoked vestibulodynia, vestibulectomy surgery, pelvic floor dysfunction, mast cell activation, birth control and vulvar pain, gaslighting in healthcare, new vulvodynia treatments
🔬 WANT TO HELP ADVANCE VULVODYNIA RESEARCH?
Dr. Goldstein emphasizes that clinical trials are crucial for developing new treatments. If you're interested in participating in vulvodynia research studies, including trials for ketotifen (mast cell stabilizer), resiniferatoxin (nerve desensitization),and Xeomin (for vulvodynia due to secondary hypertonic pelvic floor muscle dysfunction), reach out to research.cvvd@gmail.com.
Your participation could help create the breakthrough treatments of tomorrow.
RESOURCES & LINKS:
Dr. Andrew Goldstein:
- Centers for Vulvovaginal Disorders: www.vulvodynia.com
Organizations mentioned:
- International Society for the Study of Women's Sexual Health (ISSWSH): www.isswsh.org
- National Vulvodynia Association: www.nva.org
- Tight Lipped (Patient Advocacy): https://www.tightlipped.org/
Dr. Goldstein's Books:
- When Sex Hurts (2nd edition, 2022)
- Female Sexual Pain Disorders: Evaluation & Management (2nd edition, 2020)
• Reclaiming Desire (2nd edition, 2009)
Connect with the podcast: @meet.baubo or mathilde@baubo.org